BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32849451)

  • 1. Transcriptome Analysis of the
    Yang J; Yang H
    Front Microbiol; 2020; 11():1863. PubMed ID: 32849451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial Activity of
    Yang J; Yang H
    Front Cell Infect Microbiol; 2019; 9():288. PubMed ID: 31440478
    [No Abstract]   [Full Text] [Related]  

  • 3. Antagonistic activity of selenium-enriched Bifidobacterium breve against Clostridioides difficile.
    Rui W; Gu C; Zhang H; Liao X; Zhao X; Xu Y; Yang J
    Appl Microbiol Biotechnol; 2022 Sep; 106(18):6181-6194. PubMed ID: 35962282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the therapeutic effect and dose-effect of Bifidobacterium breve on the primary Clostridioides difficile infected mice.
    Yang J; Yang H
    Appl Microbiol Biotechnol; 2021 Dec; 105(24):9243-9260. PubMed ID: 34751791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Effects of Bifidobacterium breve YH68 in Combination with Vancomycin and Metronidazole in a Primary Clostridioides difficile-Infected Mouse Model.
    Yang J; Meng L; Yang H
    Microbiol Spectr; 2022 Apr; 10(2):e0067222. PubMed ID: 35311540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Bifidobacterium breve and antibiotics against Clostridioides difficile: effect of the time interval of combination on antagonistic activity.
    Yang J; Li Y; Meng L
    Int Microbiol; 2023 Nov; 26(4):833-840. PubMed ID: 36808573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of
    Yang J; Yang H
    Front Microbiol; 2018; 9():2953. PubMed ID: 30564210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated Meta-omics Reveals a Fungus-Associated Bacteriome and Distinct Functional Pathways in Clostridioides difficile Infection.
    Stewart DB; Wright JR; Fowler M; McLimans CJ; Tokarev V; Amaniera I; Baker O; Wong HT; Brabec J; Drucker R; Lamendella R
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31462412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates.
    Tijerina-Rodríguez L; Villarreal-Treviño L; Baines SD; Morfín-Otero R; Camacho-Ortíz A; Flores-Treviño S; Maldonado-Garza H; Rodríguez-Noriega E; Garza-González E
    PLoS One; 2019; 14(7):e0220671. PubMed ID: 31365590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain-Dependent RstA Regulation of Clostridioides difficile Toxin Production and Sporulation.
    Edwards AN; Krall EG; McBride SM
    J Bacteriol; 2020 Jan; 202(2):. PubMed ID: 31659010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and Characterization of the Novel Phage JD032 and Global Transcriptomic Response during JD032 Infection of Clostridioides difficile Ribotype 078.
    Li T; Zhang Y; Dong K; Kuo CJ; Li C; Zhu YQ; Qin J; Li QT; Chang YF; Guo X; Zhu Y
    mSystems; 2020 May; 5(3):. PubMed ID: 32371470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Bifidobacterium upon Clostridium difficile Growth and Toxicity When Co-cultured in Different Prebiotic Substrates.
    Valdés-Varela L; Hernández-Barranco AM; Ruas-Madiedo P; Gueimonde M
    Front Microbiol; 2016; 7():738. PubMed ID: 27242753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prebiotic-non-digestible oligosaccharides preference of probiotic bifidobacteria and antimicrobial activity against Clostridium difficile.
    Kondepudi KK; Ambalam P; Nilsson I; Wadström T; Ljungh A
    Anaerobe; 2012 Oct; 18(5):489-97. PubMed ID: 22940065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifidobacterium bifidum ATCC 15696 and Bifidobacterium breve 24b Metabolic Interaction Based on 2'-
    Centanni M; Ferguson SA; Sims IM; Biswas A; Tannock GW
    Appl Environ Microbiol; 2019 Apr; 85(7):. PubMed ID: 30683741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in acid tolerance between Bifidobacterium breve BB8 and its acid-resistant derivative B. breve BB8dpH, revealed by RNA-sequencing and physiological analysis.
    Yang X; Hang X; Tan J; Yang H
    Anaerobe; 2015 Jun; 33():76-84. PubMed ID: 25727572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Pufa Substrates on Fatty Acid Profile of Bifidobacterium breve Ncimb 702258 and CLA/CLNA Production in Commercial Semi-Skimmed Milk.
    Fontes AL; Pimentel L; Rodríguez-Alcalá LM; Gomes A
    Sci Rep; 2018 Oct; 8(1):15591. PubMed ID: 30349012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of Bifidobacteria and Lactobacilli Able to Antagonize the Cytotoxic Effect of Clostridium difficile upon Intestinal Epithelial HT29 Monolayer.
    Valdés-Varela L; Alonso-Guervos M; García-Suárez O; Gueimonde M; Ruas-Madiedo P
    Front Microbiol; 2016; 7():577. PubMed ID: 27148250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Flagellum and Toxin Phase Variation in Clostridioides difficile Ribotype 012 Isolates.
    Anjuwon-Foster BR; Maldonado-Vazquez N; Tamayo R
    J Bacteriol; 2018 Jul; 200(14):. PubMed ID: 29735765
    [No Abstract]   [Full Text] [Related]  

  • 19. Bifidobacterium breve - HT-29 cell line interaction: modulation of TNF-α induced gene expression.
    Boesten RJ; Schuren FH; Willemsen LE; Vriesema A; Knol J; De Vos WM
    Benef Microbes; 2011 Jun; 2(2):115-28. PubMed ID: 21831793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Reprogramming of
    Hofmann JD; Otto A; Berges M; Biedendieck R; Michel AM; Becher D; Jahn D; Neumann-Schaal M
    Front Microbiol; 2018; 9():1970. PubMed ID: 30186274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.